The generation of fraudulent papers is a booming industry. Providing fraudulent documents to government oversight functions is much cheaper than validating a genuine product designed to benefit people. A fine is imposed when fraud is discovered, but that is just the "cost of doing business." The pharmaceutical industry has been fined billions, but they keep churning out products and peddling them without regard for safety or effectiveness.
|